← back to search

Xuliang Luo

Nanchang University · CN
🔎 Find collaborators in Cancer Research · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Oncology
Research interest
Research focused on Breast cancer and Cancer research, with related work in Metastasis, Triple-negative breast cancer, Angiogenesis. Notable publications include 'Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice', 'SNORA71B promotes breast cancer cells across blood–brain barrier by inducing epithelial-mesenchymal transition', and 'EMT related circular RNA expression profiles identify circSCYL2 as a novel molecule in breast tumor metastasis'.
h-index
citations
172
works
7
NIH funding
primary concept
email

Recent publications

Corrigendum to “BML-111, the lipoxin A4 agonist, modulates VEGF or CoCl2-induced migration, angiogenesis and permeability in tumor-derived endothelial cells”[Immunology Letters 230 (2021) 27–35]
Immunology Letters 2022cited by 1position: middledoi
Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice
Scientific Reports 2020cited by 61position: firstdoi
SNORA71B promotes breast cancer cells across blood–brain barrier by inducing epithelial-mesenchymal transition
Breast Cancer 2020cited by 31position: middledoi
EMT related circular RNA expression profiles identify circSCYL2 as a novel molecule in breast tumor metastasis
International Journal of Molecular Medicine 2020cited by 28position: middledoi
Long noncoding RNA LINC00115 promotes breast cancer metastasis by inhibiting miR‐7
FEBS Open Bio 2020cited by 27position: middledoi
BML-111 inhibits EMT, migration and metastasis of TAMs-stimulated triple-negative breast cancer cells via ILK pathway
International Immunopharmacology 2020cited by 14position: middledoi
BML-111, the lipoxin A4 agonist, modulates VEGF or CoCl2-induced migration, angiogenesis and permeability in tumor-derived endothelial cells
Immunology Letters 2020cited by 10position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chunlei Yuan · Nanchang University4 papers (2020–2020)Lan Lin · Sun Yat-sen University Cancer Center4 papers (2020–2022)Fen Xu · Sun Yat-sen University3 papers (2020–2022)Sijia Duan · Nanchang University3 papers (2020–2020)Jing Xu · Anhui Medical University2 papers (2020–2020)Qingyu Wang · Capital Medical University2 papers (2020–2022)Huihui Zeng · China Pharmaceutical University2 papers (2020–2020)Hua Hao · Nanchang University2 papers (2020–2020)Yuanqiao He · Nanchang University2 papers (2020–2020)Liping Yan · Nanchang University2 papers (2020–2022)Manling Luo · Nanchang University1 papers (2020–2020)Liangyun Guo · Nanchang University1 papers (2020–2020)Lin Wang · Tianjin Medical University General Hospital1 papers (2020–2020)Qing Li · Chuzhou University1 papers (2020–2020)Qing Li · University Hospital of Basel1 papers (2022–2022)Hui Hu · Guangzhou University of Chinese Medicine1 papers (2020–2020)Hua Hao · Nanchang University1 papers (2022–2022)Xiang Zhan · Anhui Medical University1 papers (2020–2020)Liping Yan · Nanchang University1 papers (2020–2020)Jing Xu · University of Miami1 papers (2022–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Oncology →